Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Chuanhong Zhongfeng Capsule in Acute Cerebral Infarction
NCT06874140Phase 1Completed
- Start
- Jan 2022
- Primary completion
- Jan 2025
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Chuanhong Zhongfeng Capsule in cerebral infarction (2 arms). Primary endpoint: Protein expression levels, post-translational modifications, protein-protein interactions at 14 days. Started Jan 2022; status: completed.
02
Drugs
Chuanhong Zhongfeng Capsule
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT06874140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06874140.